Showing 35,310 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined aidsmap in 2008 and was Managing Editor from 2018 to 2024. As a freelancer, he now edits aidsmap’s news and conference coverage, as well as working on updates to About HIV pages. He is also a contributing science editor for TheBodyPro, a freelance journalist for The Lancet HIV, and a medical writer helping researchers prepare articles for peer-reviewed journals. He began working on HIV at Gay Men Fighting AIDS in the mid-1990s.

TB diagnosis

TB/HIV outreach finding patients in remote South Africa

Editor's pick
Healio
10 May 2017
Global health targets

The continuum of HIV care: What does it mean and how is Europe doing?

Editor's pick
Eurekalert Inf Dis
10 May 2017
New & experimental hepatitis C treatment

Early Access to Medicines Scheme (EAMS) Granted to AbbVie’s Investigational Pan-genotypic Regimen for Chronic Hepatitis C in UK

Editor's pick
AbbVie press release
10 May 2017
PrEP

Lib Dems say HIV prevention drug should be available on NHS

Editor's pick
Evening Standard
10 May 2017
Exposure to HIV through medical procedures

HIV blood disaster: UK families search for the truth

Editor's pick
BBC
10 May 2017
Health services & systems

Scott Gottlieb wins confirmation as FDA commissioner

Editor's pick
STAT
10 May 2017
Ageing & HIV

New Study Reveals why people with HIV are more likely to develop Emphysema

Editor's pick
Weill Cornell Medicine
10 May 2017
Harm reduction

New HRI report warns of HIV and Hepatitis C 'powder keg' in the European Union ahead of the 25th Harm Reduction International Conference (HR17)

Editor's pick
HIV / AIDS News From Medical News Today
10 May 2017
Hepatitis C treatment

BC-developed hepatitis C screening test personalizes treatment for patients

Editor's pick
The Globe and Mail
10 May 2017
Neurological & cognitive problems

Switching from efavirenz to lopinavir/ritonavir has no meaningful impact on neurological function, says UK study

News
10 May 2017

HIV update - 10th May 2017

May 2017
HIV prevention policy

Aiding and Abetting: Why Western Fundraising Fails to Stop AIDS Epidemics

Editor's pick
World Policy
9 May 2017
Harm reduction

From pill to needle: Prescription opioid epidemic may be increasing drug injection

Editor's pick
Manual Items
9 May 2017
Migrants, refugees & displaced people

Undocumented migrants more likely to be lost to follow-up and have poor virological outcomes after starting ART, Milan study confirms

News
9 May 2017
Harm reduction

Where harm reduction policies went up, hepatitis C incidence went down, study finds

Editor's pick
Science Speaks
9 May 2017
Government, leadership & policy

To End AIDS in the United States, Stay True to the National HIV/AIDS Strategy

Editor's pick
Project Inform
9 May 2017
UK health services

On borrowed time

Editor's pick
Drink & Drug News
8 May 2017
Undetectable viral load & treatment as prevention

Gay New Zealand welcomes removal of HIV meds restriction

Editor's pick
Gay New Zealand
8 May 2017
New & experimental hepatitis C treatment

Study points to new approach to battling hepatitis C infections

Editor's pick
Eurekalert
8 May 2017
PrEP

Gilead slowly rolls out ads for Truvada for PrEP — 4 years after approval

Editor's pick
Medical Marketing & Media
8 May 2017
Health services & systems

What is at Stake in ACA Repeal and Replace for People with HIV?

Editor's pick
Kaiser Family Foundation
8 May 2017
Pharmaceutical industry

The Corporate Reputation of Pharma Companies, 2016: from the Perspective of 63 HIV/AIDS Patient Groups

Editor's pick
PatientView
8 May 2017
Hepatitis B

Besifovir and tenofovir exalidex look promising as new hepatitis B drugs

News
8 May 2017
HIV prevention policy

Kenya launches self-test kits and PrEP

Editor's pick
UNAIDS
5 May 2017